uBiome Appoints Dr. Cindy Geyer, MD, Faculty at the Canyon Ranch Center for Mind-Body Medicine, to its Medical Advisory Board
SAN FRANCISCO, Nov. 21, 2018
SAN FRANCISCO, Nov. 21, 2018 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the addition of Dr. Cindy Geyer, MD, Medical Director at Canyon Ranch Lenox and Faculty Member at the Center for Mind-Body Medicine, to its Medical Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Geyer will bring to uBiome her specialization in women's health issues and the role of lifestyle choices such as food, stress, sleep, movement, connection, and communities on the microbiome and health and wellbeing. The appointment will help uBiome continue its advancement in human microbiome research.
"Dr. Geyer's 30 years of experience in internal medicine and her whole-body, collaborative approach to healthcare make her a tremendous addition to uBiome's Medical Advisory Board," said Dr. Jessica Richman, PhD, co-founder and CEO of uBiome. "We are very fortunate to have her on board."
Dr. Geyer is the Medical Director at Canyon Ranch, an innovator in their approach to health and wellness, and has been a core faculty member at The Center for Mind-Body Medicine's "Food as Medicine" conference for 18 years. She has served on the board of the American College of Lifestyle Medicine and is the editor for the case series in the American Journal of Lifestyle Medicine.
About joining uBiome's Medical Advisory Board, Dr. Geyer said, "As a clinician who works with women to improve their health through natural means, I want to empower my patients with the best tools available. uBiome is leading the way in educating patients about the importance of the microbiome to their overall health, and I'm thrilled to be joining this revolutionary effort as part of their Medical Advisory Board."
In addition to Dr. Geyer, the uBiome Scientific Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company's Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children's Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
Founded in 2012, uBiome is the leader in microbial genomics. The Company's mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.
uBiome's commercial products include SmartGut™, the world's first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome's platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company's Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.